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Abstract
Bronchitis is one of the most common acute infections
affecting pediatric patients. Most cases are caused by viral
infections, do not respond to antibiotic therapy, and can take
up to 14 days to resolve with supportive therapy. The
purpose of this study is to determine if the use of
Pelargonium Sidoides (Umcka™, EPs 7630) extract will
decrease the duration and severity of symptoms from acute
bronchitis in the pediatric population. Pelargonium Sidoides
abstract is an extract of an African Geranium that has been
used in traditional medicine for centuries. The review of the
literature will evaluate multiple randomized controlled trials
along with other studies that compare placebo, traditional
supportive therapy and Pelargonium Sidoides extract to
determine if the use of the extract will decrease severity and
duration of illness without unacceptable side effects in the
pediatric population. It has been demonstrated that
providers will be able to safely advise patients to use
Pelargonium Sidoides extract without any adverse side
effects while helping to decrease the severity and duration
of bronchitis symptoms in children. The finding indicate that
routine use of Pelargonium Sidoides may give providers an
alternative, effective and safe treatment that is well accepted
by patients and caregivers for bronchitis in pediatric
populations greater than one year of age compared to
supportive therapy

Introduction
Pelargonium Sidoides is an herbal medication that has
been used in traditional medicine for centuries. The
herbal preparation has recently regained popularity
especially with patients seeking an alternative to
traditional medications and treatments. Pelargonium
Sidoides is advertised to reduce the duration and
symptoms of acute bronchitis.

Statement of the Problem
• No known medications reduce the duration or
severity of acute bronchitis
• The health care provider has limited options to offer
these patients as antibiotics have not been found to
shorten the duration or severity of the illness

Discussion

Research Question

Will the use of Pelargonium Sidoides in children greater
than 1 year of age safely and effectively reduce the
severity and duration of acute bronchitis?
Kamin, W., FAU - Maydannik,,V.G., FAU, M. V., FAU, M. F., & Kieser, M. (2010). Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute
bronchitis. Acta Paediatr. 2010 Apr;99(4):537-43. doi: 10.1111/j.1651-2227.2009.01656.x. Epub 2010 Jan 11. Retrieved from http://www-ncbi-nlm-nihgov.ezproxy.undmedlibrary.org/pubmed/

Literature Review
–Current treatment for acute bronchitis
• McCance et al.(2010) states that treatment
consists of rest, humidity, antipyretics, and cough
suppressants
–Efficacy of Pelargonium Sidoides
• Havidvogel et al.(2007) using a BSS after one
week of treatment demonstrated a decrease of
4.7 points
• Kamin et al.(2012) used a BSS system
demonstrated a decrease of 4.4 points compared
to placebo of 2.9
• Kamin et al.(2010) compared dosing of 30,60,
and 90mg. The 60mg groups had a decrease
BSS of 4.4 points and the 90mg group a
decrease of 5.0 points compared to placebo
–Safety of Pelargonium Sidoides
• Kamin et al.(2008) noted 59 adverse events out
of 200 patients. A causal relationship was noted
in 8 events, none cited as serious. GI upset was
most prevalent
• Fau et al.(2003) demonstrated 14 adverse events
in the treatment group categorized as mild and GI
upset
–Mechanism of Action
• Michaelis et al.(2011) investigated the effects on
viral replication and demonstrated that
Pelargonium Sidoides could inhibit replication of
some viruses
• Neugebauer et al.(2005) demonstrated increased
cilary beat frequency after application of a
solution of Pelargonium Sidoides

Applicability to Clinical
Practice
 Pelargonium Sidoides can be used in addition to the
usual comfort care in the pediatric population with
acute bronchitis with very few adverse side effects
noted in research
 The research has demonstrated a reduction in
severity of cough, pulmonary rales, and dyspnea in
children with acute bronchitis compared to placebo
 Total daily dosage of 60mg-90mg
 Begin treatment with Pelargonium Sidoides within 48
hours of symptom onset
 Cost of a week long treatment ranges from $10- $15
 Pelargonium Sidoides is well tolerated by patients
and parents with the most common side effect of
gastrointestinal upset
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The best delivery and dosage of Pelargonium
Sidoides is a liquid solution with 11% ethanol
dosed at 90mg daily. This has been
demonstrated in the literature to decrease
symptom severity earliest in the disease
process
One study used a capsule to administer the
medication, no comparison was performed to
determine the best method of delivery
All studies used a Bronchitis Severity Score
(BSS) and included cough, pulmonary rales,
and dyspnea
Decrease in BSS score was greatest in all
treatment groups compared to placebo
Most common adverse events were classified
under gastrointestinal and were mild
No long term studies were performed to
investigate safety
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